IL10 and rheumatoid arthritis: With advances in synovial histopathology taking centre stage in clinical practice [2], monitoring IL-10 or inflammasome activities within the inflamed joints of patients with early RA may prove valuable as a predictor of disease activity or bone erosions, and may help tailor the design of novel treatments for defined patient groups.